MarketInOut Stock Screener Log In | Sign Up
 

Krystal Biotech Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 05/12/2026 16:00
Krystal Biotech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9,012.26 mln
Float23.37 mln
Earnings Date08/10/2026

EPS

7.46
Stretched

P / E

41.60
High premium

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.27
Borderline

1-Year Forecast

318
Fairly priced

Relative Strength

91 / 100
Top performer

Business Description

Krystal Biotech is a Pittsburgh-based biotechnology company founded in 2016 that develops and sells gene-based medicines for serious conditions that lack adequate treatment options. Its flagship product, VYJUVEK, is an approved therapy for dystrophic epidermolysis bullosa, a rare and painful skin disorder. The company also has a broad pipeline of treatments in various stages of clinical testing, targeting conditions ranging from cystic fibrosis and eye disease to certain cancers and skin conditions.

Key Fundamentals

EPS7.46
P/E41.60
ROE19.88
RPS13.85
ROIC43.40
ROA18.20
EBITDA, mln185
EV / EBITDA46.09
EV / EBIT47.96
Revenue, mln417
EV / Revenue19.86

Financial Strength

Altman Z-Score42.75
Piotroski F-Score 7 / 9
Beneish M-Score-2.27
Price to Graham Number3.64
1-Year Target Price318
Short Ratio10.01
Short % of Float16.26

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 9.05% 91 / 100   
1 Month 16.04% 85 / 100   
2 Months 11% 79 / 100   
6 Months 56.78% 92 / 100   
1 Year 135% 92 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us